MedPath

Cognitive Improvement Through tDCS for Patients With Multiple Sclerosis

Not Applicable
Active, not recruiting
Conditions
Multiple Sclerosis
Interventions
Device: Sham transcranial direct current stimulation
Device: Active transcranial direct current stimulation
Registration Number
NCT04667221
Lead Sponsor
University Medicine Greifswald
Brief Summary

Multiple sclerosis (MS) is a chronic inflammatory disease with around 200.000 patients in Germany. Besides physical symptoms, cognitive resources degrade over the years. Transcranial direct current stimulation (tDCS) is an established procedure to modulate cortical excitability in motor and cognitive functions. Therefore, tDCS may improve cognitive functions in patients with MS. Patients will work on a modified version of the symbol digits modalities test in two experimental sessions. During the task, they will receive either active stimulation or sham stimulation in a crossover design. Active stimulation is divided in anodal and cathodal stimulation. Anodal stimulation should facilitate cognitive processing; cathodal stimulation, on the other hand, should hinder cognitive processing.

Detailed Description

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease characterized by a multitude of symptoms, which greatly reduce the quality of life of patients. In addition to sensory and visual sensory disorders, movement disorders, paresis, fatigue and other physical symptoms, 65-95% of patients with MS also suffer from cognitive impairments. These cognitive impairments develop in the later course of the disease and express themselves in slower processing speed, delays in learning and memory performance, and executive dysfunction. In recent years, non-pharmacological approaches aimed at improving cognitive performance in MS have increasingly come into focus, including the transcranial direct current stimulation (tDCS).

TDCS has only been investigated in a few studies that had the aim to improve cognitive performance in MS. Further, it has only been carried out in combination with cognitive training paradigms and repeated stimulation sessions. Mattioli and colleagues (2016) could e.g. show that after 10 sessions of cognitive training with tDCS stimulation of the dorsolateral prefrontal cortex, there was greater improvement in symbol-digit modalities test (SDMT) in the experimental group than in the control group. Similarly, Charvet and colleagues (2018) showed that after 10 sessions of cognitive training with simultaneous tDCS stimulation of the dorsolateral prefrontal cortex, the experimental group showed a significant improvement in the domains of attention and response variability compared to the control group. These studies therefore reflect an interaction between cognitive training and tDCS, and do not allow any conclusions to be drawn about the effect of tDCS on specific processes. It is not yet known whether tDCS alone can positively influence specific cognitive functional impairments.

Therefore, the present study wants to investigate whether acute application of tDCS can improve specific cognitive functions. An adapted version of the clinically SDMT was conducted, as this test is one of the most widely used tests to describe cognitive impairments in MS. Based on a meta-analysis by Silva and colleagues (2018), that shows which brain areas are related to the implementation of the SDMT, the parietal cortex (BA7) is stimulated bilaterally with either excitatory (anodal) or inhibitory (cathodal) tDCS.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • diagnosis of multiple sclerosis.
  • no acute inflammation during the last 3 months before the experimental intervention.
  • no cortisol treatment during the last 3 months before the experimental intervention.
  • stable medication during the experimental intervention.
  • unrestrained or corrected visual ability.
  • ability to read and write short german sentences.
  • adequate motor ability to give responses on a keyboard.
  • German as main language.
Exclusion Criteria
  • major depressive symptoms or any further neurological and/or psychiatric disease at experimental intervention.
  • standard tDCS exclusion criteria (e.g. cardiac pacemaker, metal implants in head region, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sham transcranial direct current stimulation for anodal groupSham transcranial direct current stimulationPatients will be bilaterally stimulated with sham tDCS at the parietal cortex (Brodmann Area 7). As a consequence of the crossover design, both experimental arms receive sham stimulation.
Sham transcranial direct current stimulation for cathodal groupSham transcranial direct current stimulationPatients will be bilaterally stimulated with sham tDCS at the parietal cortex (Brodmann Area 7). As a consequence of the crossover design, both experimental arms receive sham stimulation.
Anodal transcranial direct current stimulationActive transcranial direct current stimulationPatients will be bilaterally stimulated with anodal tDCS at the parietal cortex (Brodmann Area 7).
Cathodal transcranial direct current stimulationActive transcranial direct current stimulationPatients will be bilaterally stimulated with cathodal tDCS at the parietal cortex (Brodmann Area 7).
Primary Outcome Measures
NameTimeMethod
Reaction Times in symbol-digit modalities test.Assessed at two timepoints (1x during active (anodal/cathodal) tDCS intervention at Day 1 or 7 (depends on randomization), 1x during sham tDCS intervention at Day 1 or 7 (depends on randomization))

Reaction times in milliseconds for the performance of the symbol-digit modalities test.

Secondary Outcome Measures
NameTimeMethod
Hit Rate in symbol-digit modalities test.Assessed at two timepoints (1x during active (anodal/cathodal) tDCS intervention at Day 1 or 7 (depends on randomization), 1x during sham tDCS intervention at Day 1 or 7 (depends on randomization))

Hit rate in percentage of correct responses in the symbol-digit modalities test.

Baseline performance in symbol-digit modalities test.Assessment at baseline (Day 0, before stimulation).

Baseline performance of paper-pencil version of the symbol-digit modalities test as a predictor for the stimulation effect.

Trial Locations

Locations (1)

University Medicine Greifswald

🇩🇪

Greifswald, Germany

© Copyright 2025. All Rights Reserved by MedPath